Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Monolaurin, a monoglyceride derived from lauric acid (found in coconut oil and human breast milk), has been studied for its antimicrobial properties, particularly against bacteria, viruses, and fungi. Laboratory (in vitro) studies have shown that monolaurin can disrupt the lipid membranes of certain enveloped viruses (such as influenza, herpes simplex, and HIV) and inhibit the growth of some pathogenic bacteria (like Staphylococcus aureus and Streptococcus species). These findings suggest a potential mechanism where monolaurin destabilizes the pathogen's lipid envelope, leading to its inactivation. However, the majority of supportive evidence comes from test tube and animal studies, not from robust human clinical trials. There are very few well-designed, peer-reviewed clinical trials evaluating the efficacy of monolaurin in treating or preventing contagious diseases in humans. While some practitioners and supplement manufacturers promote monolaurin for immune support and as an adjunct to fight viral and bacterial infections, the current scientific evidence in humans is limited and inconclusive. Thus, while there is a scientific rationale and preliminary laboratory evidence to support its use against certain pathogens, the lack of high-quality, large-scale human studies limits the strength of this recommendation. More research is needed to establish effective dosages, safety, and clinical efficacy for the treatment or prevention of contagious diseases.

More about monolaurin
More about Contagious Diseases

Other ingredients used for Contagious Diseases

Other health conditions supported by monolaurin

Products containing monolaurin